News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kaye Edward M. MD
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 448 shares
@ $27.88, valued at
$12.5k
|
|
| 07/05/2023 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 374 shares
@ $33.36, valued at
$12.5k
|
|
| 05/18/2023 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $37.89, valued at
$378.9k
|
|
| 04/05/2023 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 298 shares
@ $37.71, valued at
$11.2k
|
|
| 03/17/2023 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 213,000 options to buy
@ $9.15, valued at
$1.9M
Granted 142,000 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 253 shares
@ $44.35, valued at
$11.2k
|
|
| 12/09/2022 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 167,050 options to buy
@ $7.07, valued at
$1.2M
|
|
| 10/05/2022 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 220 shares
@ $51.11, valued at
$11.2k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 293 shares
@ $38.38, valued at
$11.2k
|
|
| 03/17/2022 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 308,000 options to buy
@ $20.34, valued at
$6.3M
|
|
| 01/04/2022 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 244 shares
@ $46, valued at
$11.2k
|
|
| 12/23/2021 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 15,000 shares
@ $45, valued at
$675k
Exercised 15,000 options to buy
@ $7.61, valued at
$114.2k
|
|
| 10/04/2021 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 306 shares
@ $36.74, valued at
$11.2k
|
|
| 07/08/2021 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 63 shares
@ $19.77, valued at
$1.2k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Kaye Edward M. MD (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $26.09, valued at
$391.4k
|
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 200,800 options to buy
@ $60, valued at
$12M
|
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $0.6, valued at
$6k
|
|
| 12/18/2020 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 19,806 shares
@ $60, valued at
$1.2M
Sold 5,194 shares
@ $60, valued at
$311.6k
|
|
| 11/30/2020 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 12,152 shares
@ $50, valued at
$607.6k
|
|
| 11/25/2020 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 12,848 shares
@ $50, valued at
$642.4k
|
|
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2020 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Exercised 50,000 options to buy
@ $0.6, valued at
$30k
|
|
| 03/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|